Impingement Syndrome Market

Impingement Syndrome Market, By Type of Musculoskeletal Disorder (Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Back and Neck Pain, Shoulder Impingement Syndrome, Knee Pain and Disorders, Hip Pain and Disorders, Trauma and Fracture, Sports Injuries, Other Musculoskeletal Disorders), By Diagnosis and Imaging Techniques (X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Ultrasound, Arthroscopy, Others), By Treatment Modalities (Medications, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Physical Therapy and Rehabilitation, Corticosteroid Injections, Surgical Interventions), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Orthopedic Centers, Rehabilitation Centers, Others), By Age Group (Pediatric and Adolescent Population, Adult Population, Geriatric Population) By Gender (Male, Female), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Impingement syndrome refers to the narrowing of the subacromial space, leading to impingement of the tendons of the rotator cuff muscles. It is a condition in which the tendons of the rotator cuff of the shoulder are pinched as they pass between the top of the upper arm (humerus) and the tip of the shoulder (acromion). Impingement syndrome treatment can range from simple home treatment such as aspirin and rest to surgery, depending on how severe the impingement is.

Market Dynamics:

Increasing prevalence of musculoskeletal disorders, growing geriatric population, rise in demand for safe & effective treatment, and increasing research and development are major factors expected to augment the growth of the global impingement syndrome market.

For instance, according to the World Health Organization (WHO), July 2022, around 1.71 billion people across the globe worldwide have musculoskeletal conditions. Musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the leading cause of disability in 160 countries. WHO has launched Rehabilitation 2030 Initiative to support countries to respond to existing rehabilitation needs, including of people with musculoskeletal conditions, as well as the forecasted increase arising from health and demographic trends.

Key features of the study:

This report provides in-depth analysis of the global impingement syndrome market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.

It profiles key players in the global impingement syndrome market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include Bioventus LLC, Orthofix Medical Inc., Breg, Inc., CONMED Corporation, Össur hf., DJO Global, Inc., Arthrex, Inc., Wright Medical Group N.V., Globus Medical, Inc., NuVasive, Inc., Smith & Nephew plc, Stryker Corporation, Medtronic plc, Zimmer Biomet Holdings, Inc., and Johnson & Johnson (DePuy Synthes), among others.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

The global impingement syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global impingement syndrome market.

Detailed Segmentation:

Global Impingement Syndrome Market, By Type of Musculoskeletal Disorder:

Osteoarthritis

Rheumatoid Arthritis

Osteoporosis

Back and Neck Pain

Shoulder Impingement Syndrome

Knee Pain and Disorders

Hip Pain and Disorders

Trauma and Fracture

Sports Injuries

Other Musculoskeletal Disorders

Global Impingement Syndrome Market, By Diagnosis and Imaging Techniques:

X-ray

Magnetic Resonance Imaging (MRI)

Computed Tomography (CT) Scan

Ultrasound

Arthroscopy

Others

Global Impingement Syndrome Market, By Treatment Modalities:

Medications:

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Analgesics

Steroids

Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

Physical Therapy and Rehabilitation

Corticosteroid Injections

Surgical Interventions:

Arthroscopic Surgery

Joint Replacement Surgery

Other Orthopedic Surgeries

Global Impingement Syndrome Market, By End User:

Hospitals and Clinics

Ambulatory Surgical Centers

Orthopedic Centers

Rehabilitation Centers

Others

Global Impingement Syndrome Market, By Age Group:

Pediatric and Adolescent Population

Adult Population

Geriatric Population

Global Impingement Syndrome Market, By Gender:

Male

Female

Global Impingement Syndrome Market, By Region:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Company Profiles:

Bioventus LLC

Orthofix Medical Inc.

Breg, Inc.

CONMED Corporation

Össur hf.

DJO Global, Inc.

Arthrex, Inc.

Wright Medical Group N.V.

Globus Medical, Inc.

NuVasive, Inc.

Smith & Nephew plc

Stryker Corporation

Medtronic plc

Zimmer Biomet Holdings, Inc.

Johnson & Johnson (DePuy Synthes)